Drawing on MHLW and Tokyo Metropolitan Government guidance and live online-pharmacy flows: why Class-1 medicines cannot be ordered directly, and what a pharmacist confirmation is expected to ask before a purchase can proceed.
What PMDA recall information, Yellow Letters, Blue Letters and PMDA Medinavi each mean, plus a step-by-step checklist for what to do when a medicine you use is recalled or flagged.
Reading Japan’s iPS-based regenerative medicine through Amchepry, Heartseed HS-005 and the PMDA conditional, time-limited approval pathway — why it draws attention, and why the results still need careful interpretation.
What BNCT, proton beam and heavy-ion (carbon-ion) therapy each differ on: indication boundaries, current clinical-research status, and the documents worth preparing before making an enquiry.
A safety checklist drawn from published guidance by the FDA, NABP, TGA, EMA and GPhC: the prescription, licence, pharmacist and price signals worth checking before buying medicine online.
How prescription transfer, automatic refills, pharmacist support, delivery tracking and health content combine into sustainable pharmacy services across the US, UK and Australia.
What changes in Japan’s medicine sales system from May 2026: online medication guidance for guidance-required medicines, specified guidance-required medicines, designated abuse-prevention medicines, and the implications for cross-border purchase pages.
Japan has completed the first catheter-delivered administration of iPS-derived cardiomyocyte spheroids. A look at the EMERALD trial, the difference between HS-001 and HS-005, and the wider cardiac regenerative-medicine landscape after ReHeart’s approval.
Tokushima University Hospital has completed the first TUFF-IPC autologous transplant. What type 1 diabetes involves, the limits of islet transplantation, how the adipose-derived approach works, and why this remains early-stage clinical research.
Japan’s National Cancer Center is running a Phase I/II basket trial of BNCT for thoracic solid tumours. The trial design, who it is recruiting, how BNCT works, and the limitations patients should keep in mind.
